Ms. Dilber et al., Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22, GENE THER, 6(1), 1999, pp. 12-21
We demonstrate that fusion proteins consisting of the herpes simplex virus
(HSV) transport protein VP22 linked in frame to HSV thymidine kinase (tk) r
etain the ability to be transported between cells. In vivo radiolabelling e
xperiments and in vitro assays show that the fusion proteins also retain tk
activity. When transfected COS cells. acting as a source of the VP22-tk ch
imera, were co-plated on to gap junction-negative neuroblastoma cells, ganc
iclovir treatment induced efficient cell death in the recipient neuroblasto
ma cell monolayer. No such effect was observed with COS cells transfected w
ith tk alone. Tumours established in mice with neuroblastoma cell lines exp
ressing VP22-tk regressed upon administration of ganciclovir. Furthermore t
umours established from 50:50 mixtures of VP22-tk transduced and nontransdu
ced cells also regressed while no significant effect was observed in simila
r experiments with cells transduced with tk alone. VP22 mediated transport
may thus have application in a clinical setting to amplify delivery of the
target protein in enzyme-prodrug protocols.